comprehensive -WSS

comprehensive

author：entertainment 2025-10-01 22:57:26 - browse：88233

The Biden administration moved Wednesday to force insurance companies to give specific reasons for denying coverage, and to speed up the pre-approval process in general.

The new rule applies to health insurance companies that offer Medicare, Medicaid, Children’s Health Insurance Program, and Obamacare plans. It concerns so-called prior authorization requests, and will require insurers to return urgent requests within 72 hours and non-urgent requests within seven days.

The changes are a win for patients seeking care, but also for health care providers like hospitals and physicians. Executives from California-based Sutter Health, Massachusetts General Brigham, and others repeatedly cited the rise in insurer denials since the pandemic at last week’s J.P. Morgan Healthcare conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： The Bio Revolution is changing business and society

WSS

Lawsuit challenges CMS nursing home minimum staffing rule

Why we need mandatory labeling of GMO products

Bernie Sanders gets little from pharma CEOs on drug prices

New research sheds light on how often breast cancer is overdiagnosed

Latigo launches with $135 million for Vertex

Here’s what’s in the FDA plan to include pregnant women in clinical trials

focus

comprehensive

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Congress must protect the remaining independent doctors

Novavax promises a turnaround & Lilly roils the obesity market

Long Covid research funding gets a major boost from NIH

New air purifier tech could be key to improving indoor air quality

Artificial intelligence use in health care faces greater scrutiny in 2024

Duchenne breakthrough therapy leaves behind pioneering families

AMAs digital advisors table RPM coding reform proposal, again

Hepatitis C has a cure — but many Americans still lack access to it

Report cites 'urgent' need to recruit more diverse clinical trial participants

entertainment

New research sheds light on how often breast cancer is overdiagnosed

Guardant Health colon cancer test endorsed by FDA advisory panel

Congress considering partial increase for doctor pay in Medicare

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Congress: Prevent baby formula shortages by passing a new bill

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

hotspot

focus

focus

hotspot